EPS Creative Health Technology Group Strengthens Capabilities Through Executive Appointments 
Cornerstone Robotics Hosts Inaugural ‘Surgical Futures Forum’, Global Leaders Gather in Hong Kong to Chart the Next Frontier of Accessible Surgical Care Through Robotics & Innovation 
Cloudbreak Pharma Inc. (02592.HK) Unveils Phase III Topline Data for CBT-001: The First Randomized, Double-Blind Validation of a Drug Treatment for Pterygium 
Indonesia Hit Its Rice Targets. Prices Still Won’t Sit Still. 
HEALWELL More than Doubles YoY Adjusted EBITDA in Q3-2026 and Improves YTD Operating Cashflow by $26 Million Centessa Pharmaceuticals Announces Orphan Drug Designation Granted to SerpinPC for the Treatment of Hemophilia B
– Registrational studies planned to start in 4Q 2022 – – Two-year data from Phase…
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
Key leadership appointments focused on enhancing connections and collaboration to drive Innovation across the next-generation delivery…
Todos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista Diagnostics
Follows CDC & World Health Organization’s (WHO) announcement that US now meets criteria for country with circulating…
Hillstream BioPharma to Participate in the Fierce Biotech Summit on September 19-20
BRIDGEWATER, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or…
Portage Biotech Provides Research and Development Update
–The Company Highlights its Clinical Strategy for its Adenosine and iNKT Platforms– –Clinical Development Goals…
SELLAS Life Sciences to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’…
Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.
– Transaction values Apollomics at pre-money equity value of $899 million – Apollomics is a…
Oncotelic Presenting Data for OT101 Against Diffuse Intrinsic Pontine Glioma (DIPG) at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
AGOURA HILLS, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
TOWER ONE WIRELESS ANNOUNCES TWENTY- SIX TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $2,600,000
TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF AUGUST 2022 VANCOUVER, BC, CANADA , Sept….
Upcoming Presentation at Joint Meeting of ISBRA and ESBRA to Highlight Potential of Hepion Pharmaceutical’s Rencofilstat to Treat Alcohol-Related Liver Disease
EDISON, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
All Merger-related proposals approved at the Annual Meeting of Stockholders BASKING RIDGE, N.J., Sept. 14,…
eFFECTOR Therapeutics Doses First Patient in Second Cohort of Phase 1b Clinical Trial of Zotatifin for the Treatment of COVID-19
– Dose escalation based on positive recommendation from independent data safety monitoring board after safety…
Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014
TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
TRACON Pharmaceuticals Announces Fast Track Designation by the FDA for Envafolimab for the Treatment of the Soft Tissue Sarcoma Subtypes of UPS and MFS
SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Pardes Biosciences Appoints Laurie Smaldone Alsup, M.D. and John C. Pottage, Jr., M.D. to Board of Directors
CARLSBAD, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc. (Nasdaq: PRDS), a clinical-stage…
Adverum Biotechnologies Announces First Subject Dosed with Ixo-vec in the Phase 2 LUNA Trial for the Treatment of Wet Age-Related Macular Degeneration
LUNA Phase 2 Study in Wet AMD – Study Design Objective: The LUNA trial is…
Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital Ichthyosis
European Commission expected to issue its decision on orphan designation in approximately 30 days BASKING…
CymaBay Therapeutics Hosting Virtual Analyst Day on September 22
Redefining Expectations for PBC Patients September 22, 2022 at 10:30 AM ET NEWARK, Calif., Sept….
SOTIO Bolsters Leadership Team with Appointment of Martin Steegmaier as Chief Scientific Officer
PRAGUE, Czech Republic, Sept. 14, 2022 (GLOBE NEWSWIRE) — SOTIO Biotech, a clinical stage immuno-oncology…
Immutep Clinical Development Update for its First-in-Class LAG-3 Antigen Presenting Cell Activator Candidate Eftilagimod Alpha
Encouraging Phase II data supports broad therapeutic potential of eftilagimod alpha in non-small cell lung…